Published in J Autism Dev Disord on September 01, 1982
Autism profiles of males with fragile X syndrome. Am J Ment Retard (2008) 2.35
Autism spectrum phenotype in males and females with fragile X full mutation and premutation. J Autism Dev Disord (2007) 2.28
Autistic behavior in young boys with fragile X syndrome. J Autism Dev Disord (1998) 1.91
Adult fragile X syndrome. Clinico-neuropathologic findings. Acta Neuropathol (1985) 1.80
Molecular and cognitive predictors of the continuum of autistic behaviours in fragile X. Neurosci Biobehav Rev (2006) 1.58
Longitudinal changes in cognitive and adaptive behavior scores in children and adolescents with the fragile X mutation or autism. J Autism Dev Disord (2002) 1.54
Autism in fragile X syndrome: a category mistake? J Am Acad Child Adolesc Psychiatry (2010) 1.30
Secondary medical diagnosis in fragile X syndrome with and without autism spectrum disorder. Am J Med Genet A (2008) 1.20
Autism Genetic Database (AGD): a comprehensive database including autism susceptibility gene-CNVs integrated with known noncoding RNAs and fragile sites. BMC Med Genet (2009) 1.11
Language Development in Individuals with Fragile X Syndrome. Top Lang Disord (2009) 1.03
Why are autism and the fragile-X syndrome associated? Conceptual and methodological issues. Am J Hum Genet (1991) 0.97
Autistic behaviors among girls with fragile X syndrome. J Autism Dev Disord (1997) 0.94
A voxel-based morphometry comparison of regional gray matter between fragile X syndrome and autism. Psychiatry Res (2009) 0.89
Brief report: electroencephalographic paroxysmal activities in the frontal area emerged in middle childhood and during adolescence in a follow-up study of autism. J Autism Dev Disord (1997) 0.88
Dynamic Object Representations in Infants with and without Fragile X Syndrome. Front Hum Neurosci (2010) 0.85
The cyclic AMP phenotype of fragile X and autism. Neurosci Biobehav Rev (2008) 0.83
The fragile X syndrome: the patients and their chromosomes. J Med Genet (1984) 0.83
Autism Spectrum Disorder (ASD) and Fragile X Syndrome (FXS): Two Overlapping Disorders Reviewed through Electroencephalography-What Can be Interpreted from the Available Information? Brain Sci (2015) 0.80
Using infrared eye-tracking to explore ordinal numerical processing in toddlers with Fragile X Syndrome. J Neurodev Disord (2013) 0.79
[The approach of cognitive neuropsychology toward the studies on autism]. J Psychiatry Neurosci (1994) 0.77
Brief report: autistic behaviors among children with fragile X or Rett syndrome: implications for the classification of pervasive developmental disorder. J Autism Dev Disord (1998) 0.77
Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med (1991) 7.17
A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature (2001) 6.78
The effect of metallic salts on the glycolysis and respiration of tissues. Biochem J (1928) 5.87
Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med (1991) 5.30
Invitation to attend a health check in a general practice setting: comparison of attenders and non-attenders. J R Coll Gen Pract (1988) 5.27
Australia develops national strategy for bringing physicians to rural areas. CMAJ (1994) 4.61
Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J Biol Chem (2001) 4.51
T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates. Nat Med (1998) 3.95
Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study--preliminary data. Am J Med Genet (1999) 3.82
Chemotactic and anaphylatoxic fragment cleaved from the fifth component of guinea pig complement. Science (1968) 3.69
The heart of the matter: Dalton Camp and his controversial transplant. CMAJ (1993) 3.21
Somatic mutations in the neurofibromatosis 1 gene in human tumors. Cell (1992) 3.20
Multi-disciplinary clinical study of Smith-Magenis syndrome (deletion 17p11.2) Am J Med Genet (1996) 3.17
A hemodynamic model of the pathogenesis of age-related macular degeneration. Am J Ophthalmol (1997) 3.11
Can the uptake of breast screening by Asian women be increased? A randomized controlled trial of a linkworker intervention. J Public Health Med (1994) 3.04
Mutations in familial Creutzfeldt-Jakob disease and Gerstmann-Sträussler-Scheinker's syndrome. Exp Neurol (1989) 3.00
Foetal thymic transplant in a case of Digeorge's syndrome. Lancet (1968) 2.85
Relation between parasuicide, suicide, psychiatric admissions, and socioeconomic deprivation. BMJ (1995) 2.83
Analysis of neocortex in three males with the fragile X syndrome. Am J Med Genet (1991) 2.70
Managed care: devils, angels, and the truth in between. Health Prog (1999) 2.68
Transient symptomatic hypotension in patients on simvastatin. Lancet (1989) 2.67
Cost effectiveness of shortening screening interval or extending age range of NHS breast screening programme: computer simulation study. BMJ (1998) 2.61
Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test. JAMA (1993) 2.59
Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet (1993) 2.57
Experience with nontreatment of central serous choroidopathy. Arch Ophthalmol (1974) 2.51
Alzheimer neurofibrillary tangles in diseases other than senile and presenile dementia. Ann Neurol (1979) 2.50
Randomized phase III study 306: adjunctive perampanel for refractory partial-onset seizures. Neurology (2012) 2.45
Pigmentary epitheliopathy and erythema nodosum. Arch Ophthalmol (1971) 2.39
Evidence of founder chromosomes in fragile X syndrome. Nat Genet (1992) 2.38
Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice. Cancer Res (1997) 2.34
A complex mutable polymorphism located within the fragile X gene. Nat Genet (1993) 2.33
Locomotion in larval zebrafish: Influence of time of day, lighting and ethanol. Neurotoxicology (2008) 2.12
Detection and surveillance of colorectal cancer. JAMA (1989) 2.07
Bowel function of long-term tube-fed patients consuming formulae with and without dietary fiber. JPEN J Parenter Enteral Nutr (1990) 2.06
T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residues. J Exp Med (1994) 2.04
Adenovirus-mediated gene transfer to ciliated airway epithelia requires prolonged incubation time. J Virol (1996) 1.98
Case report. Metastatic pulmonary calcification in renal failure: a new HRCT pattern. Br J Radiol (2002) 1.95
The International Collaborative Study of Maternal Phenylketonuria: status report 1998. Eur J Pediatr (2000) 1.91
Production and characterization of monoclonal antibodies specific for a glycosylated polypeptide of human cytomegalovirus. J Clin Microbiol (1983) 1.91
Nontuberculous mycobacteria in bronchiectasis: Prevalence and patient characteristics. Eur Respir J (2006) 1.91
Chemical structure of the exine of pollen walls and a new function for carotenoids in nature. Nature (1968) 1.91
High frequency of BRCA1 185delAG mutation in ovarian cancer in Israel. National Israel Study of Ovarian Cancer. JAMA (1996) 1.90
SSCP is not so difficult: the application and utility of single-stranded conformation polymorphism in evolutionary biology and molecular ecology. Mol Ecol (2000) 1.87
Antipneumococcal effects of C-reactive protein and monoclonal antibodies to pneumococcal cell wall and capsular antigens. Infect Immun (1989) 1.86
Mutations of the Gs alpha-subunit gene in Albright hereditary osteodystrophy detected by denaturing gradient gel electrophoresis. Proc Natl Acad Sci U S A (1990) 1.82
Adult fragile X syndrome. Clinico-neuropathologic findings. Acta Neuropathol (1985) 1.80
Cancer risks among BRCA1 and BRCA2 mutation carriers. Br J Cancer (2007) 1.77
The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population. Am J Hum Genet (2002) 1.77
Brain-derived neurotrophic factor modulates nociceptive sensory inputs and NMDA-evoked responses in the rat spinal cord. J Neurosci (1999) 1.77
What price survival? The future of Blue Cross and Blue Shield. JAMA (1998) 1.75
Genotype-phenotype correlations in Peutz-Jeghers syndrome. J Med Genet (2004) 1.73
A mouse model for the learning and memory deficits associated with neurofibromatosis type I. Nat Genet (1997) 1.71
Epigenetic variation illustrated by DNA methylation patterns of the fragile-X gene FMR1. Hum Mol Genet (1997) 1.70
Detection of Trichomonas vaginalis in pregnant women with the InPouch TV culture system. J Clin Microbiol (1993) 1.68
The uninsured. From dilemma to crisis. JAMA (1991) 1.65
Carcinoid tumors frequently display genetic abnormalities involving chromosome 11. J Clin Endocrinol Metab (1996) 1.65
Slicing the pie thinner: hospitals and physicians square off over primary care services. Hospitals (1982) 1.64
Prevention of diabetes in nonobese diabetic mice by dendritic cell transfer. J Clin Invest (1992) 1.64
The role of the atherosclerotic process in the pathogenesis of age-related macular degeneration. Am J Ophthalmol (2000) 1.63
Impaired learning in mice with abnormal short-lived plasticity. Curr Biol (1996) 1.63
Epidemiology and patterns of hospital use after parasuicide in the south west of England. J Epidemiol Community Health (1996) 1.62
Fragile X gene instability: anchoring AGGs and linked microsatellites. Am J Hum Genet (1995) 1.61
Prediction of early course of breast carcinoma by thymidine labeling. Cancer (1983) 1.61
Coping with calamity. How well does health care disaster planning work? JAMA (1994) 1.61
Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study. BJU Int (2010) 1.60
Effect of BRCA mutations on the length of survival in epithelial ovarian tumors. J Clin Oncol (2002) 1.60
Misconceptions about cholesterol. N Z Med J (1990) 1.60
Mount St Helens eruptions, May 18 to June 12, 1980. An overview of the acute health impact. JAMA (1981) 1.59
Health education and knowledge assessment of HTLV-III diseases among intravenous drug users. Health Educ Q (1986) 1.58
Inheritance of mitral valve prolapse: effect of age and sex on gene expression. Ann Intern Med (1982) 1.58
Fragile X and autism: a multicenter survey. Am J Med Genet (1986) 1.56
The LRRK2 G2019S mutation is associated with Parkinson disease and concomitant non-skin cancers. Neurology (2012) 1.56
Autosomal recessive catecholamine- or exercise-induced polymorphic ventricular tachycardia: clinical features and assignment of the disease gene to chromosome 1p13-21. Circulation (2001) 1.56
Infant astigmatism: its disappearance with age. Vision Res (1980) 1.55
Detection of full fragile X mutation. Lancet (1992) 1.55
Malignant fibrous histiocytoma: an institutional review. Cancer Invest (2001) 1.54
New evidence for neurotransmitter influences on brain development. Trends Neurosci (1997) 1.53
Familial transmission of the FMR1 CGG repeat. Am J Hum Genet (1996) 1.53
Relapse after cognitive behavior therapy of depression: potential implications for longer courses of treatment. Am J Psychiatry (1992) 1.53
Congenital webs, cysts, laryngoceles and other anomalies of the larynx. Ann Otol Rhinol Laryngol (1967) 1.51
CD4+ T-cell responses to Epstein-Barr virus (EBV) latent-cycle antigens and the recognition of EBV-transformed lymphoblastoid cell lines. J Virol (2005) 1.49
Canada's first private MRI clinic: does it signal a shift to two-tiered medicine? CMAJ (1993) 1.48
Superiority of "triple" therapy with salmeterol/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPD. Thorax (2008) 1.47
Evidence that methylation of the FMR-I locus is responsible for variable phenotypic expression of the fragile X syndrome. Am J Hum Genet (1993) 1.47
ATM haplotypes and breast cancer risk in Jewish high-risk women. Br J Cancer (2006) 1.47
The FRAXE Syndrome: is it time for routine screening? Am J Hum Genet (1996) 1.46
Postnatal confirmation of prenatally diagnosed trisomy 16 mosaicism in two phenotypically abnormal liveborns. Prenat Diagn (1994) 1.46
Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study. Pain (1999) 1.45
Trends in heterosexual tertiary students' knowledge of HIV and intentions to avoid people who might have HIV. AIDS Care (1996) 1.45